Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Mu

Showing results (31-40 of 331) with videos related to

Pageof 34
Sort By:
Scientific Reports|May 27, 2026
A high-dimensional steady-state structural framework for regional transmission interface capacity planning using physics-embedded graph representation learningDongliang Zhang, Ying Mu, Dashun Guan, et al.
Dalton Transactions (Cambridge, England : 2003)|March 25, 2011
Half-zirconocene anilide complexes: synthesis, characterization and catalytic properties for ethylene polymerization and copolymerization with 1-hexeneKefeng Liu, Qiaolin Wu, Wei Gao, et al.
Acta Crystallographica. Section E, Structure Reports Online|November 9, 2011
[(E)-10-(2,6-Dimethyl-phenyl-imino)-9-methyl-9,10-dihydro-phenanthren-9-olato]penta-methyl-dialuminum(III)Bo Gao, Qing Su, Wei Gao, et al.
Journal of Nanoscience and Nanotechnology|November 3, 2004
Methods for labeling quantum dots to biomoleculesZhangbi Lin, Xingguang Su, Ying Mu, et al.
Journal of Molecular Recognition : JMR|April 16, 2018
Study on a 65-mer peptide mimetic enzyme with GPx and SOD dual functionJuxin Yin, Jianjian Zhuang, Shaowu Lv, et al.
Pakistan Journal of Medical Sciences|February 25, 2026
Proliferative double-negative T (DNT)-cell responses to PD-1 blockade therapy were positively correlated with good clinical outcomes in non-small cell lung cancer patientsYing Mu, Xiaofang Wei, Yukun Wang, et al.
Frontiers in Immunology|August 29, 2024
Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms: a systematic review and meta-analysisChanghui Zhou, Weihua Wang, Ying Mu, et al.
Journal of Hematology & Oncology|June 5, 2013
Targeted therapy for HER2 positive breast cancerJason A Incorvati, Shilpan Shah, Ying Mu, et al.
The Journal of Pain|November 21, 2017
Inflammatory Renin-Angiotensin System Disruption Attenuates Sensory Hyperinnervation and Mechanical Hypersensitivity in a Rat Model of Provoked VestibulodyniaAnuradha Chakrabarty, Zhaohui Liao, Ying Mu, et al.
BMC Pharmacology & Toxicology|December 26, 2014
Modeling skin sensitization potential of mechanistically hard-to-be-classified aniline and phenol compounds with quantum mechanistic propertiesQin Ouyang, Lirong Wang, Ying Mu, et al.
Pageof 34

Showing results (31-40 of 331) with videos related to

Sort By:
Pageof 34
Scientific Reports|May 27, 2026
A high-dimensional steady-state structural framework for regional transmission interface capacity planning using physics-embedded graph representation learningDongliang Zhang, Ying Mu, Dashun Guan, et al.
Dalton Transactions (Cambridge, England : 2003)|March 25, 2011
Half-zirconocene anilide complexes: synthesis, characterization and catalytic properties for ethylene polymerization and copolymerization with 1-hexeneKefeng Liu, Qiaolin Wu, Wei Gao, et al.
Acta Crystallographica. Section E, Structure Reports Online|November 9, 2011
[(E)-10-(2,6-Dimethyl-phenyl-imino)-9-methyl-9,10-dihydro-phenanthren-9-olato]penta-methyl-dialuminum(III)Bo Gao, Qing Su, Wei Gao, et al.
Journal of Nanoscience and Nanotechnology|November 3, 2004
Methods for labeling quantum dots to biomoleculesZhangbi Lin, Xingguang Su, Ying Mu, et al.
Journal of Molecular Recognition : JMR|April 16, 2018
Study on a 65-mer peptide mimetic enzyme with GPx and SOD dual functionJuxin Yin, Jianjian Zhuang, Shaowu Lv, et al.
Pakistan Journal of Medical Sciences|February 25, 2026
Proliferative double-negative T (DNT)-cell responses to PD-1 blockade therapy were positively correlated with good clinical outcomes in non-small cell lung cancer patientsYing Mu, Xiaofang Wei, Yukun Wang, et al.
Frontiers in Immunology|August 29, 2024
Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms: a systematic review and meta-analysisChanghui Zhou, Weihua Wang, Ying Mu, et al.
Journal of Hematology & Oncology|June 5, 2013
Targeted therapy for HER2 positive breast cancerJason A Incorvati, Shilpan Shah, Ying Mu, et al.
The Journal of Pain|November 21, 2017
Inflammatory Renin-Angiotensin System Disruption Attenuates Sensory Hyperinnervation and Mechanical Hypersensitivity in a Rat Model of Provoked VestibulodyniaAnuradha Chakrabarty, Zhaohui Liao, Ying Mu, et al.
BMC Pharmacology & Toxicology|December 26, 2014
Modeling skin sensitization potential of mechanistically hard-to-be-classified aniline and phenol compounds with quantum mechanistic propertiesQin Ouyang, Lirong Wang, Ying Mu, et al.
Pageof 34